Roles of sensitization to staphylococcus enterotoxin in patients with obstructive lung diseases
C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), N. Tashima (Kyoto, Japan), Y. Ishiyama (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Nagasaki (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan)
Source: International Congress 2019 – Clinical aspects of airway diseases
Session: Clinical aspects of airway diseases
Session type: Thematic Poster
Number: 2762
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), N. Tashima (Kyoto, Japan), Y. Ishiyama (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Nagasaki (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan). Roles of sensitization to staphylococcus enterotoxin in patients with obstructive lung diseases. 2762
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Roles of sensitization to Staphylococcal enterotoxin in patients with bronchiectasis Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: 240-244 Year: 2007
Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
Are antibiotics useful in acute exacerbations of chronic bronchitis? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=189 Year: 2004
Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa : resistance to common antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001
Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Airway infection in COPD Year: 2019
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017
Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020 Year: 2020
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
Impacts on Mycoplasma pneumoniae infection in acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Mucus production in chronic obstructive lung diseases: relationship with infections Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006
Analysis of pathogenic secretory immunity factors in saliva from patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007
Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence? Source: Eur Respir J 2002; 19: 387-389 Year: 2002
The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002
Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010